Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Acquired by Barclays PLC

Barclays PLC boosted its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 342.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,439 shares of the company’s stock after purchasing an additional 41,358 shares during the quarter. Barclays PLC’s holdings in Viemed Healthcare were worth $392,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Wasatch Advisors LP increased its holdings in shares of Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after purchasing an additional 303,277 shares during the period. Apis Capital Advisors LLC grew its position in Viemed Healthcare by 193.0% in the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after buying an additional 154,400 shares during the last quarter. Renaissance Technologies LLC increased its stake in Viemed Healthcare by 50.9% in the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after buying an additional 147,900 shares during the period. Victory Capital Management Inc. raised its position in Viemed Healthcare by 748.2% during the 3rd quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock worth $795,000 after buying an additional 95,706 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY lifted its stake in shares of Viemed Healthcare by 25.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock worth $2,620,000 after acquiring an additional 80,000 shares during the period. Institutional investors and hedge funds own 74.24% of the company’s stock.

Insider Buying and Selling

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the business’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the sale, the director now directly owns 126,843 shares in the company, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 72,256 shares of company stock valued at $674,739. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Stock Down 0.1 %

Shares of NASDAQ:VMD opened at $8.12 on Friday. The company has a market cap of $316.17 million, a price-to-earnings ratio of 30.07 and a beta of 1.46. Viemed Healthcare, Inc. has a fifty-two week low of $6.21 and a fifty-two week high of $10.44. The firm’s 50-day simple moving average is $8.60 and its 200-day simple moving average is $7.82. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $58.00 million during the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.